RxDoctor Payments Data

Viseslav Tonkovic Capin, MD

Dermatology · Leawood, KSNPI 1932215506

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 31 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 11 manufacturers reported payments, led by Amgen at 36.4% of the total. That places this record below the midpoint for dermatology clinicians in KS, where the typical reported total is $1,741.

$851in general payments, 2019–2025

Across 31 payments — averaging $27.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$310
  • Novartis$104
  • Regeneron Healthcare Solutions, Inc.$92
  • E.r. Squibb & Sons, L.L.C.$86
  • Lilly USA, LLC$65
  • Aroa Biosurgery Incorporated$60
  • plus $133 from 5 others

What the payments were for

  • Food & beverage$851100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$851 in reported general payments places this provider in the 35th percentile of 82 dermatology providers in Kansas.

See all dermatology providers in Kansas

Medicare billing

Part B allowed, 2024
$106,495
Medicare patients
307
Services billed
2,869

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OtezlaApremilast47$253,280
Cosentyx Unoready PenSecukinumab12$103,243
Calcipotriene20$3,211
Clobetasol Propionate62$3,187
Ketoconazole165$3,008
Clindamycin Phosphate13$795
CiclopiroxCiclopirox Olamine23$575
Metronidazole12$545
Ciclopirox11$324
Mupirocin24$221
Ampicillin Trihydrate13$176
Triamcinolone Acetonide21$139
ValacyclovirValacyclovir Hcl12$118
Hydrocortisone13$59

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AmgenOtezla$310$253,28047 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 35th percentile of 82 dermatology providers in Kansas.

Other dermatology in Leawood

See the full list for Kansas

Where these figures come from

Is this you, or does something look wrong? →